Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AZD2115 in COPD
NCT01498081Phase 2Completed
- Sponsor
- AstraZeneca
- Start
- Mar 2012
- Primary completion
- Oct 2012
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of azd2115 in chronic obstructive pulmonary disease (COPD), sponsored by AstraZeneca. Started Mar 2012; status: completed.
02
Drugs
azd2115
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT01498081.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01498081.